CLINICAL_TRIALS trial_result · 2014-03-26

Clinical Trial Update: Can TNF-Alpha Incomplete Secondary Responders Attain a Safe and Efficacious Response Switching to Cimzia [Phase 4]

Summary

Phase 4 trial assessing whether rheumatoid arthritis patients with incomplete secondary response to TNF inhibitors can achieve a safe and effective response aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

Snippet

Sponsor: Michael Schiff, MD | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2014-03-26